background
influenza
respiratori
diseas
serious
threaten
human
health
fact
influenza
viru
make
critic
contribut
mortal
induc
influenza
cytokin
storm
produc
excess
immun
respons
trigger
viru
result
inflammatori
reaction
lung
tissu
fatal
lung
tissu
injuri
thu
increas
influenza
mortal
therefor
besid
antivir
drug
immunosuppress
drug
also
includ
infect
treatment
present
hypothesi
complement
center
inflammatori
reaction
complement
system
activ
bodi
strong
inflammatori
reaction
tissu
injuri
result
patholog
process
mani
studi
prove
inflammatori
injuri
lung
tissu
caus
influenza
viru
close
relat
complement
activ
therefor
inhibit
complement
activ
significantli
reduc
inflammatori
injuri
lung
tissu
complement
physiolog
defens
patholog
damag
medium
systemat
inhibit
may
result
side
effect
includ
infect
therefor
design
target
complement
inhibitor
complement
activ
site
ie
target
vector
complement
inhibitor
like
crri
target
inflammatori
site
special
inhibit
complement
activ
local
injuri
thu
local
inflammatori
reaction
inhibit
test
hypothesi
target
complement
inhibitor
fusionexpress
biolog
activ
examin
via
vivo
vitro
test
target
complement
inhibitor
use
treat
mous
influenza
viral
pneumonia
model
pb
treatment
group
control
surviv
lung
tissu
injuri
mice
observ
effect
target
complement
inhibitor
pneumonia
induc
influenza
viru
evalu
implic
hypothesi
target
complement
inhibitor
expect
ideal
drug
viral
pneumonia
influenza
acut
infecti
diseas
caus
influenza
viru
respiratori
damag
main
outcom
epidemiolog
character
rapid
preval
wide
dissemin
acut
incid
huge
hazard
one
diseas
serious
threaten
human
health
report
world
health
organ
show
million
sever
influenza
case
mortal
everi
year
influenza
pandemia
happen
four
time
th
centuri
spanish
flu
seriou
one
claim
million
live
least
even
mortal
fist
world
war
peopl
die
flu
influenza
produc
larg
number
morbid
mortal
also
result
great
econom
loss
social
burden
reaction
immun
system
import
reason
patient
mortal
oda
et
al
point
symptom
influenza
inflammatori
injuri
result
immun
activ
influenza
viru
instead
directli
induc
influenza
viru
immun
system
activ
case
invas
influenza
viru
studi
shown
influenza
viru
invad
human
cell
cytokin
chemotat
factor
stimul
produc
mani
inflammatori
protein
help
defens
viru
chemotat
factor
cytokin
messeng
immun
system
play
import
role
coordin
regul
immun
respons
influenza
viru
enter
lung
tissu
immun
system
lose
control
make
reaction
releas
mani
cytokin
like
cytokin
storm
immun
system
run
control
induc
sever
inflamm
result
indirect
hazard
may
induc
inflamm
damag
lung
final
result
fatal
pneumonia
acut
respiratori
tract
infect
syndrom
indic
influenza
patient
requir
antivir
drug
immunosuppress
drug
studi
shown
inflammatori
injuri
lung
tissu
main
fatal
reason
influenza
bird
flu
sar
septicemia
aspir
pneumonia
liver
infect
induc
anthrax
bacillu
well
complement
import
conserv
system
natur
immun
provid
pathway
rapid
effect
elimin
invas
microorgan
bridg
natur
immun
acquir
immun
besid
direct
immun
mechan
complement
also
releas
mani
type
small
molecular
fragment
broad
biolog
effect
chemotaxi
neutrophil
lymphocyt
phagocytosi
particip
regul
immun
respons
cell
bodi
fluid
addit
complement
system
also
import
medium
inflamm
immun
reaction
pose
great
potenti
threat
bodi
complement
system
activ
mani
complement
compon
consum
reduc
antiinfect
abil
bodi
mani
activ
substanc
deriv
activ
induc
sever
inflammatori
reaction
tissu
injuri
result
patholog
process
exampl
complement
activ
produc
inflammatori
media
includ
kininlik
function
expand
small
vessel
improv
permeabl
anaphylatoxin
function
degranul
mast
cell
basophil
releas
vasoact
mediat
induc
inflammatori
reaction
chemotaxi
function
attract
inflammatori
cell
concentr
migrat
toward
inflammatori
region
activ
complement
thu
increas
inflammatori
reaction
central
molecul
immun
respons
regul
complement
system
split
product
molecul
includ
deposit
activ
cell
surfac
specif
ligand
molecul
good
choic
tartet
vector
deliveri
complement
inhibitor
crri
site
inflamm
induc
complement
activ
mani
studi
indic
target
complement
inhibitor
significantli
mitig
inflammatori
reaction
local
site
crri
import
complement
regulatori
protein
ideal
complement
inhibitor
interfer
combin
complex
inhibit
format
membran
attack
complex
mac
crri
block
complement
activ
inhibit
activ
convertas
mani
studi
prove
excess
inflammatori
injuri
lung
tissu
induc
influenza
viru
infect
close
relat
complement
activ
complement
activ
affect
influenza
virusspecif
immun
respons
lung
infect
influenza
viru
mice
see
signific
decreas
tcell
reaction
complement
activ
play
import
role
tcell
activ
recruit
martin
found
induc
neutrophil
migrat
lung
infect
influenza
viru
studi
show
complement
activ
follow
influenza
viru
infect
significantli
influenc
pulmonari
infiltr
lung
injuri
degre
hohenth
u
nuutila
j
found
complement
receptor
strong
express
influenza
viral
pneumonia
kase
found
human
mbl
directli
indirectli
remov
influenza
viru
particl
inhibit
viral
transmiss
complement
activ
opson
coupl
influenza
antigen
ha
increas
level
antiinfluenza
viru
ha
antibodi
reduc
activ
threshold
bcell
improv
intens
immun
respons
paula
longhi
et
al
found
mice
inflect
influenza
viru
seriou
pneumonia
wildtyp
signific
pulmonari
hemorrhag
leukocyt
infiltr
neutrophil
lymphocyt
aggreg
lung
cell
fibrosi
tcell
activ
inject
complement
inhibitor
mice
improv
lung
inflammatori
reaction
signific
neutrophil
infiltr
decreas
studi
indic
inhibit
complement
activ
excess
inflammatori
reaction
lung
tissu
induc
influenza
inhibit
result
lung
tissu
injuri
mitig
mortal
reduc
complement
physiolog
defens
patholog
damag
medium
function
doubleedg
sword
systemat
complement
inhibit
may
result
potenti
side
effect
includ
infect
therefor
design
target
complement
inhibitor
complement
activ
site
target
vector
complement
inhibitor
like
crri
target
inflammatori
site
special
inhibit
complement
activ
local
injuri
thu
local
inflammatori
reaction
inhibit
without
side
effect
caus
systemat
inhibit
test
hypothesi
gene
respect
link
gene
complement
inhibitor
includ
crri
fusion
express
cho
cell
purifi
cultur
supernat
affin
chromatographi
biolog
activ
target
complement
inhibitor
examin
vivo
vitro
test
balbc
mice
appli
inhal
mous
lungadapt
virul
strain
influenza
viru
via
nose
duplic
influenza
pneumonia
model
mice
mice
treat
target
complement
inhibitor
pb
treatment
group
control
final
work
observ
surviv
lung
tissu
injuri
mice
evalu
effect
target
complement
inhibitor
influenza
viral
pneumonia
effect
target
complement
inhibitor
reduc
mortal
significantli
improv
clinic
symptom
decreas
weight
lung
index
hemagglutin
titer
lung
tissu
inflammatori
injuri
virusinfect
model
group
therefor
target
complement
inhibitor
expect
ideal
drug
viral
pneumonia
